Blog RSS

Children’s antibodies highly potent against COVID-19: study

czelusa — Tue, 30 Jan 2024 22:01:52 +0000

Children’s antibodies highly potent against COVID-19: study czelusa Tue, 01/30/2024 - 16:01 RSS:

https://news.vumc.org/2023/11/06/childrens-antibodies-highly-potent-against-covid-19-study/

Lockdown Auth

James Crowe’s antibody research lands American Society for Microbiology Award

czelusa — Tue, 30 Jan 2024 21:59:59 +0000

James Crowe’s antibody research lands American Society for Microbiology Award czelusa Tue, 01/30/2024 - 15:59 RSS:

https://news.vumc.org/2023/09/13/james-crowes-antibody-research-lands-american-society-for-microbiology-award/

Lockdown Auth

Researchers discover antibody that neutralizes both RSV and hMPV

czelusa — Tue, 30 Jan 2024 21:59:17 +0000

Researchers discover antibody that neutralizes both RSV and hMPV czelusa Tue, 01/30/2024 - 15:59 RSS:

https://news.vumc.org/2023/08/04/researchers-discover-antibody-that-neutralizes-both-rsv-and-hmpv/

Lockdown Auth

VUMC, Oxford team develops ‘blueprint’ to block lethal virus

czelusa — Tue, 11 Jul 2023 16:24:01 +0000

VUMC, Oxford team develops ‘blueprint’ to block lethal virus czelusa Tue, 07/11/2023 - 11:24 RSS:

https://news.vumc.org/2023/06/22/vumc-oxford-team-develops-blueprint-to-block-lethal-virus/

Lockdown Auth

Scientists resurrect a ‘dead’ antibody to study protein

czelusa — Tue, 11 Jul 2023 16:21:38 +0000

Scientists resurrect a ‘dead’ antibody to study protein czelusa Tue, 07/11/2023 - 11:21 RSS:

https://news.vumc.org/2023/03/16/scientists-resurrect-a-dead-antibody-to-study-protein/

Lockdown Auth

Crowe’s research honored

czelusa — Tue, 04 Apr 2023 21:34:12 +0000

Crowe’s research honored czelusa Tue, 04/04/2023 - 16:34 RSS:

https://news.vumc.org/2023/03/23/crowes-research-honored/

Lockdown Auth

Laura Handal & Kat Webb Personal Graphical Abstract

czelusa — Tue, 14 Mar 2023 21:08:17 +0000

Laura Handal & Kat Webb Personal Graphical Abstract czelusa Tue, 03/14/2023 - 16:08 RSS:

Get to know a little bit more about our newest graduate students, Laura Handal and Kat Webb!

Lockdown Auth

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

czelusa — Mon, 06 Feb 2023 17:14:46 +0000

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections czelusa Mon, 02/06/2023 - 11:14 RSS:

https://news.vumc.org/2023/02/02/discovery-of-cross-reactive-antibodies-could-aid-treatment-of-viral-co-infections/

Lockdown Auth

Antibody “fingerprinting” method potential advance to slow spread of dengue

czelusa — Tue, 24 Jan 2023 22:38:27 +0000

Antibody “fingerprinting” method potential advance to slow spread of dengue czelusa Tue, 01/24/2023 - 16:38 RSS:

https://news.vumc.org/2023/01/12/antibody-fingerprinting-method-potential-advance-to-slow-spread-of-dengue/

Lockdown Auth

Slideshow: Behind the Bench

czelusa — Mon, 05 Dec 2022 19:42:52 +0000

Slideshow: Behind the Bench czelusa Mon, 12/05/2022 - 13:42 RSS:

Behind the Bench: A Celebration of Vanderbilt's Contribution to to COVID-19 Research was an amazing time! We enjoyed hearing from the perspectives of people in the lab and what it was like to be on the frontiers of research during a time of global uncertainty and hardship.

Lockdown Auth

Slideshow: 2022 Holiday Party

czelusa — Fri, 02 Dec 2022 16:45:12 +0000

Slideshow: 2022 Holiday Party czelusa Fri, 12/02/2022 - 10:45 RSS:

Lockdown Auth

Dr. Crowe listed as a Clarivate Highly Cited Researchers of 2022

czelusa — Fri, 02 Dec 2022 16:38:38 +0000

Dr. Crowe listed as a Clarivate Highly Cited Researchers of 2022 czelusa Fri, 12/02/2022 - 10:38 RSS:

https://news.vumc.org/2022/11/17/several-from-vumc-among-most-highly-cited-researchers/

Lockdown Auth

Evusheld Named One of Time Magazine's Best Invention of 2022

czelusa — Fri, 02 Dec 2022 16:36:12 +0000

Evusheld Named One of Time Magazine's Best Invention of 2022 czelusa Fri, 12/02/2022 - 10:36 RSS:

https://time.com/collection/best-inventions-2022/6229895/astrazeneca-evusheld/

Lockdown Auth

Slideshow: Inaugural VVC Pumpkin Carving!

czelusa — Sun, 30 Oct 2022 19:41:36 +0000

Slideshow: Inaugural VVC Pumpkin Carving! czelusa Sun, 10/30/2022 - 14:41 RSS:

Lockdown Auth

Reporter: COVID antibody research conducted at VUMC lands national award

czelusa — Wed, 07 Sep 2022 17:23:53 +0000

Reporter: COVID antibody research conducted at VUMC lands national award czelusa Wed, 09/07/2022 - 12:23 RSS:

https://news.vumc.org/2022/08/24/covid-antibody-research-conducted-at-vumc-lands-national-award/

Lockdown Auth

Lauren Williamson Places Second in Merck KGaA Innovation Cup

czelusa — Mon, 29 Aug 2022 01:28:26 +0000

Lauren Williamson Places Second in Merck KGaA Innovation Cup czelusa Sun, 08/28/2022 - 20:28 RSS:

Lauren Williamson talks about her experience at the 2022 Merck KGaA Innovation Cup

Lauren Williamson, Ph.D., a staff scientist in the laboratory of James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, placed second in the 2022 Merck KGaA Innovation Cup as part of Team Autoimmunity.

The 2022 Merck KGaA Innovation cup took place between July 23-29 and hosted seven teams ranging from oncology, immunology, digital health and more. The teams worked to develop innovative ideas for unmet medical challenges and built a business case to pitch to industry executives. Of the over 3,500 applicants, Merck KGaA invited just 42 finalists to Frankfurt, Germany, for the competition.

As part of Team Autoimmunity, Williamson devised a method of stabilizing cell populations that play essential roles in autoimmune disorders through foxtags, an acronym created for this project. While Williamson is required to adhere to nondisclosure agreements, she was able to say that foxtags work with a variety of diseases rather than a single disorder.

Williamson said that participating in the competition was, “Very inspiring. Both the research and being able to work with a group of great scientists from around the world,” and that, “it really takes a diverse team to peruse great science and make new, innovative discoveries.”

Williamson joined Vanderbilt as part of the Interdisciplinary Graduate Program in 2015 and wrote her dissertation on the neutralization mechanisms of anti-alphavirus human monoclonal antibodies in the Crowe Lab.

Her current work focuses on virology and immunology. Williamson currently studies additional virus families such as picornaviruses.

She credits her experience at the Vanderbilt Vaccine Center for much of her success, stating, “my work focuses not just on publications but also moving things into the clinic. Knowing what the industry is looking for in a product made a major difference.”

As part of the runner-up team, Williamson was awarded 5,000 euros (approximately $5,100 at the time) and the chance for her project to be considered as a future Merck KGaA product.

Lockdown Auth

Recap on this past April's Symposium on Modeling Immunity

Visitor — Thu, 20 Jul 2017 18:59:59 +0000

Recap on this past April's Symposium on Modeling Immunity Visitor Thu, 07/20/2017 - 13:59 RSS:

https://my.vanderbilt.edu/universityfundingprograms/2017/07/symposium-on-modeling-immunity-recap/

Lockdown Auth

Hantavirus case confirmed in Seattle area

Visitor — Thu, 20 Jul 2017 17:21:56 +0000

Hantavirus case confirmed in Seattle area Visitor Thu, 07/20/2017 - 12:21 RSS:

http://www.kiro7.com/news/local/hantavirus-case-confirmed-in-skagit-county/541937571

Lockdown Auth

Live, Learn, Research: Next Generation Vaccine Development

Visitor — Wed, 28 Jun 2017 20:33:22 +0000

Live, Learn, Research: Next Generation Vaccine Development Visitor Wed, 06/28/2017 - 15:33 RSS:

https://www.youtube.com/watch?v=pOmLNeUE2X8

Dr. Crowe along with Dr. Jens Meiler discuss their groundbreaking research into shaping the future of vaccines.

Lockdown Auth

Unraveling the Mystery of Immunity | Dr. James Crowe, Jr. | TEDxNashville

Visitor — Tue, 09 May 2017 05:00:00 +0000

Unraveling the Mystery of Immunity | Dr. James Crowe, Jr. | TEDxNashville Visitor Tue, 05/09/2017 - 00:00 RSS:

https://www.youtube.com/watch?v=YfuS3__1a-k&feature=youtu.be

James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center explores in his TedTalk the world of pandemics. He discusses the ever-growing debate of whether the world of microbial pathogens or the human immune system is the larger source of conflict, and what research is doing to solve this ever-important question.

Lockdown Auth